N@N

GenMark Diagnostics Schedules Fourth Quarter and Fiscal Year 2010 Financial Results and Conference Call for March 3, 2011

_{//health-fitness.news-articles.net/content/2011/ .. esults-and-conference-call-for-march-3-2011.html}
^{Published in Health and Fitness on Tuesday, February 22nd 2011 at 14:55 GMT by Market Wire}  

CARLSBAD, Calif.--([ BUSINESS WIRE ])--GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its fourth quarter and fiscal year 2010 earnings results following the close of market on Thursday, March 3, 2011. Management will hold a conference call to review the company's fourth quarter and fiscal year 2010 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the GenMark Diagnostics, Inc. website at [ www.genmarkdx.com ] under the investor relations section and will be archived for future reference.

To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number "18654547" approximately five minutes prior to the start time.

About GenMark

GenMark, a provider of automated, multiplex molecular diagnostic testing systems, detects and measures DNA and RNA targets to diagnose disease and to optimize the treatment of patients and is focused on developing and commercializing its eSensor detection technology. GenMark's XT-8 System is designed to support a broad range of molecular diagnostic tests with a compact and easy-to-use workstation and self-contained, disposable test cartridges. GenMark has developed five diagnostic tests for use with the XT-8 System, including its Cystic Fibrosis Genotyping Test, Warfarin Sensitivity Test and Thrombophilia Risk Test which have received clearance from the Food and Drug Administration.